Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A pancreatic intraductal papillary mucinous neoplasm characterized by the presence of a focal or multifocal invasive carcinomatous component. The invasive carcinoma is either colloid or ductal adenocarcinoma.
Biomarker and diagnostic research for pancreatic intraductal papillary-mucinous neoplasm with an associated invasive carcinoma has been reported in the published literature.
No clinical trials have been registered for pancreatic intraductal papillary-mucinous neoplasm with an associated invasive carcinoma.
128 publications have been identified in PubMed for pancreatic intraductal papillary-mucinous neoplasm with an associated invasive carcinoma. Research spans Review / Meta-Analysis (23%), Epidemiology / Natural History (22%), and Diagnostic / Biomarker (16%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 29 |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 5:50 PM UTC
Disease patterns and progression | 28 | 22% |
Testing and diagnosis research | 21 | 16% |
Laboratory research | 17 | 13% |
Clinical study results | 16 | 13% |
Patient case studies | 15 | 12% |
Other research | 1 | 1% |
New treatment approaches | 1 | 1% |
Bakkaloglu IG (2026). [PMID: 41813527](https://pubmed.ncbi.nlm.nih.gov/41813527/). *Semin Diagn Pathol*. [Review / Meta-Analysis]
Nardi P (2026). [PMID: 41469095](https://pubmed.ncbi.nlm.nih.gov/41469095/). *Anticancer Res*. [Review / Meta-Analysis]
Kumar P (2026). [PMID: 41350134](https://pubmed.ncbi.nlm.nih.gov/41350134/). *Surgery*. [Diagnostic / Biomarker]
Jung H (2026). [PMID: 42136141](https://pubmed.ncbi.nlm.nih.gov/42136141/). *Cancer Med*. [Diagnostic / Biomarker]
Cui M (2026). [PMID: 41381181](https://pubmed.ncbi.nlm.nih.gov/41381181/). *Gut*. [Basic Science / Preclinical]
Kannan A (2026). [PMID: 41432930](https://pubmed.ncbi.nlm.nih.gov/41432930/). *JAMA Surg*. [Basic Science / Preclinical]
Tashiro Y (2026). [PMID: 40522384](https://pubmed.ncbi.nlm.nih.gov/40522384/). *Abdom Radiol (NY)*. [Review / Meta-Analysis]
Lee G (2026). [PMID: 41320174](https://pubmed.ncbi.nlm.nih.gov/41320174/). *J Gastroenterol Hepatol*. [Diagnostic / Biomarker]
De Robertis R (2026). [PMID: 41192204](https://pubmed.ncbi.nlm.nih.gov/41192204/). *Eur J Radiol*. [Review / Meta-Analysis]
Woo J (2026). [PMID: 41707038](https://pubmed.ncbi.nlm.nih.gov/41707038/). *Anal Chem*. [Diagnostic / Biomarker]